CVS Corp (CVS) 93.61 $CVS
CVS Health Increasing Access to Health Care with Annual Project Health Campaign
PR Newswire - Wed Sep 07, 7:00AM CDT
In its continuing commitment to help improve access to health care for all Americans, CVS Health (NYSE: CVS) today announced the rollout of Project Health, its annual free health services campaign, at select CVS Pharmacy locations in 10 multicultural communities across the country. Beginning Thursday, September 8 and running through December 18, nearly $8 million worth of free health services will be delivered at more than 500 Project Health events.
CVS: 93.61 (+0.25)
Water Street Appoints Nicklaus Daley to Vice President
PR Newswire - Tue Sep 06, 11:32AM CDT
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has appointed Nicklaus Daley to vice president. Mr. Daley augments Water Street's team of senior investment professionals and former executives of health care corporations including Baxter International Inc., CVS Caremark Corporation, Johnson & Johnson and McKesson Corporation.
JNJ: 119.61 (-0.14), BAX: 45.90 (-0.05), CVS: 93.61 (+0.25)
CVS Health to Host Third Annual In-Store Campaign to Support Innovative Cancer Research
PR Newswire - Tue Sep 06, 7:00AM CDT
CVS Health, the nation's largest pharmacy innovation company, launched an in-store fundraising campaign today at CVS Pharmacy locations nationwide to benefit Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation, that supports innovative cancer research that gets new therapies to patients quickly to save more lives.
CVS: 93.61 (+0.25)
CVS to pay Massachusetts $795K, tighten policies for opioids
AP - Thu Sep 01, 1:30PM CDT
BOSTON (AP) — CVS Health Corp. has agreed to pay Massachusetts $795,000 and will tighten its policies for dispensing opioids following an investigation into its drug prescription practices, Attorney General Maura Healey said Thursday.
CVS: 93.61 (+0.25)
CVS Health To Present At The Morgan Stanley Global Healthcare Conference
PR Newswire - Wed Aug 31, 11:00AM CDT
CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be speaking to investors at the Morgan Stanley Global Healthcare Conference on September 13, 2016, at approximately 8:00 a.m. ET.
CVS: 93.61 (+0.25)
Target's chief marketing officer to leave, join Uber
By ANNE D'INNOCENZIO - AP - Tue Aug 30, 1:26PM CDT
NEW YORK (AP) — Target's chief marketing officer is leaving the company and heading to Uber.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25)
CVS Caremark (CVS) Approaches New Downside Target of $91.91
Comtex SmarTrend(R) - Tue Aug 30, 9:17AM CDT
Shares of CVS Caremark (NYSE:CVS) have bearishly opened below the pivot of $93.02 today and have reached the first support level of $92.50. Analysts will be watching for a cross of the next downside pivot targets of $91.91 and $90.80.
CVS: 93.61 (+0.25)
Pharmacy Benefit Managers Improperly Reinterpret Medicare Rules For Financial Gain
PR Newswire - Tue Aug 30, 8:40AM CDT
A new White Paper from the Community Oncology Alliance (COA) looks at recent moves by Pharmacy Benefit Managers (PBMs) to increase corporate profits by declaring all physician dispensing to be out-of-network. Prepared for COA by attorneys at the law firm, Frier Levitt, LLC, the White Paper "Pharmacy Benefit Managers' Attack on Physician Dispensing and Impact on Patient Care," examines recent PBM actions, notably CVS Caremark's announced intent to restrict patient access to physician dispensing, effective January 1, 2017.
CVS: 93.61 (+0.25)
Florida Based Pharmacy Loses Close to 330 Monthly Prescriptions After CVS Caremark Contracts Florida Based Medicaid HMO Plan
GlobeNewswire - Mon Aug 29, 4:00AM CDT
The following is a statement by Pharmacists United for Truth and Transparency (PUTT):
CVS: 93.61 (+0.25)
CVS Caremark Set to Possibly Rebound After Yesterday's Selloff of 2.54%
Comtex SmarTrend(R) - Thu Aug 25, 12:02PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $94.31 to a high of $96.97. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $96.31 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 93.61 (+0.25)
CVS Health and Easterseals Celebrate Ten Years of Partnership to Support our Nation's Young Children on Their Path to Better Health
PR Newswire - Wed Aug 24, 6:00AM CDT
Through investments of more than $1.5 million in early childhood services at Easterseals in the past decade, CVS Health has been instrumental in assuring tens of thousands of young children get the best possible start in life.
CVS: 93.61 (+0.25)
CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations
PR Newswire - Mon Aug 22, 7:30AM CDT
A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent is extraordinarily cost-effective. The study, published today in The American Journal of Managed Care, also found an even greater opportunity for cost-savings if medication adherence resources are focused on patients with three or more chronic co-morbidities, such as hypertension, diabetes and high cholesterol. In fact, a preliminary analysis shows that payers could save approximately $38-$63 million per 100,000 members by focusing resources on these specific patient populations.
CVS: 93.61 (+0.25)
After Target (TGT) Earnings, Should Walmart (WMT) Investors Worry?
Ryan McQueeney - Zacks Investment Research - Wed Aug 17, 2:27PM CDT
Target missed revenue expectations and slashed its guidance for the remainder of the year, which could be a sign of things to come for Walmart (WMT), another giant in the value shopping sphere that is set to report this week.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), WMT: 72.06 (-0.94), AAPL: 108.36 (+0.66)
Three Reasons For Target's Weak Q2 Sales
Ryan McQueeney - Zacks Investment Research - Wed Aug 17, 1:18PM CDT
Target pointed to these three areas to explain why its same-store sales declined.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), AAPL: 108.36 (+0.66)
CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Colorado
PR Newswire - Wed Aug 17, 8:30AM CDT
CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Colorado. CVS Health has established a standing order with physicians in Colorado that allows CVS Pharmacy to expand access to the medication across the state.
CVS: 93.61 (+0.25)
Can Target Withstand Amazon’s Wrath?
ESTMZ - Tue Aug 16, 3:30PM CDT
Target Corp ( TGT ) Consumer Discretionary - Multiline Retail | Reports August 17, Before Market Opens Key Takeaways The Estimize consensus is looking for earnings per share of $1.14 on $16.25 billion in revenue, 1 cent higher than Wall street...
AMZN: 784.48 (-4.39), SPY: 219.01 (-0.02), TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), WMT: 72.06 (-0.94)
5 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Tue Aug 16, 3:00PM CDT
Target ( TGT ): The discounter is the fifth largest retailer in the world, after Walmart, CVS, Walgreens and Home Depot. While Walmart has traditionally been a direct competitor for Target, it’s Amazon that is now becoming a bigger threat. Over the...
SPLS: 8.79 (+0.22), AMZN: 784.48 (-4.39), HD: 132.79 (-1.31), SPY: 219.01 (-0.02), WBA: 82.88 (+1.24), PLCE: 83.03 (-0.06), AEO: 18.46 (+0.06), TGT: 70.30 (+0.20), WMT: 72.06 (-0.94), CVS: 93.61 (+0.25), LOW: 75.44 (-0.57)
CVS Caremark (CVS) Breaks Through Support at $97.25
Comtex SmarTrend(R) - Tue Aug 16, 8:47AM CDT
Shares of CVS Caremark (NYSE:CVS) opened today below their pivot of $97.46 and have already reached the first level of support at $97.25. Investors may be interested in a cross of the next downside pivot targets of $96.92 and $96.38.
CVS: 93.61 (+0.25)
CVS Health Survey Reveals Two in Five Americans Make Multiple Trips to get Entire Household Vaccinated against the Flu
PR Newswire - Tue Aug 16, 7:30AM CDT
A new survey from CVS Health (NYSE:CVS) released today found that more than one-third (34 percent) of U.S. adults who have ever received the flu shot determine where to get vaccinated based on convenience. Specific convenience factors that would make Americans more likely to have themselves and their families vaccinated against the flu include having the vaccine readily available without an appointment (28 percent) and being able to get the entire family vaccinated at one place/time (20 percent).
CVS: 93.61 (+0.25)
CVS Health Increasing Access to Health Care with Annual Project Health Campaign
PR Newswire - Wed Sep 07, 7:00AM CDT
In its continuing commitment to help improve access to health care for all Americans, CVS Health (NYSE: CVS) today announced the rollout of Project Health, its annual free health services campaign, at select CVS Pharmacy locations in 10 multicultural communities across the country. Beginning Thursday, September 8 and running through December 18, nearly $8 million worth of free health services will be delivered at more than 500 Project Health events.
CVS: 93.61 (+0.25)
Water Street Appoints Nicklaus Daley to Vice President
PR Newswire - Tue Sep 06, 11:32AM CDT
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has appointed Nicklaus Daley to vice president. Mr. Daley augments Water Street's team of senior investment professionals and former executives of health care corporations including Baxter International Inc., CVS Caremark Corporation, Johnson & Johnson and McKesson Corporation.
JNJ: 119.61 (-0.14), BAX: 45.90 (-0.05), CVS: 93.61 (+0.25)
CVS Health to Host Third Annual In-Store Campaign to Support Innovative Cancer Research
PR Newswire - Tue Sep 06, 7:00AM CDT
CVS Health, the nation's largest pharmacy innovation company, launched an in-store fundraising campaign today at CVS Pharmacy locations nationwide to benefit Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation, that supports innovative cancer research that gets new therapies to patients quickly to save more lives.
CVS: 93.61 (+0.25)
CVS to pay Massachusetts $795K, tighten policies for opioids
AP - Thu Sep 01, 1:30PM CDT
BOSTON (AP) — CVS Health Corp. has agreed to pay Massachusetts $795,000 and will tighten its policies for dispensing opioids following an investigation into its drug prescription practices, Attorney General Maura Healey said Thursday.
CVS: 93.61 (+0.25)
CVS Health To Present At The Morgan Stanley Global Healthcare Conference
PR Newswire - Wed Aug 31, 11:00AM CDT
CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be speaking to investors at the Morgan Stanley Global Healthcare Conference on September 13, 2016, at approximately 8:00 a.m. ET.
CVS: 93.61 (+0.25)
Target's chief marketing officer to leave, join Uber
By ANNE D'INNOCENZIO - AP - Tue Aug 30, 1:26PM CDT
NEW YORK (AP) — Target's chief marketing officer is leaving the company and heading to Uber.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25)
CVS Caremark (CVS) Approaches New Downside Target of $91.91
Comtex SmarTrend(R) - Tue Aug 30, 9:17AM CDT
Shares of CVS Caremark (NYSE:CVS) have bearishly opened below the pivot of $93.02 today and have reached the first support level of $92.50. Analysts will be watching for a cross of the next downside pivot targets of $91.91 and $90.80.
CVS: 93.61 (+0.25)
Pharmacy Benefit Managers Improperly Reinterpret Medicare Rules For Financial Gain
PR Newswire - Tue Aug 30, 8:40AM CDT
A new White Paper from the Community Oncology Alliance (COA) looks at recent moves by Pharmacy Benefit Managers (PBMs) to increase corporate profits by declaring all physician dispensing to be out-of-network. Prepared for COA by attorneys at the law firm, Frier Levitt, LLC, the White Paper "Pharmacy Benefit Managers' Attack on Physician Dispensing and Impact on Patient Care," examines recent PBM actions, notably CVS Caremark's announced intent to restrict patient access to physician dispensing, effective January 1, 2017.
CVS: 93.61 (+0.25)
Florida Based Pharmacy Loses Close to 330 Monthly Prescriptions After CVS Caremark Contracts Florida Based Medicaid HMO Plan
GlobeNewswire - Mon Aug 29, 4:00AM CDT
The following is a statement by Pharmacists United for Truth and Transparency (PUTT):
CVS: 93.61 (+0.25)
CVS Caremark Set to Possibly Rebound After Yesterday's Selloff of 2.54%
Comtex SmarTrend(R) - Thu Aug 25, 12:02PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $94.31 to a high of $96.97. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $96.31 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 93.61 (+0.25)
CVS Health and Easterseals Celebrate Ten Years of Partnership to Support our Nation's Young Children on Their Path to Better Health
PR Newswire - Wed Aug 24, 6:00AM CDT
Through investments of more than $1.5 million in early childhood services at Easterseals in the past decade, CVS Health has been instrumental in assuring tens of thousands of young children get the best possible start in life.
CVS: 93.61 (+0.25)
CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations
PR Newswire - Mon Aug 22, 7:30AM CDT
A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent is extraordinarily cost-effective. The study, published today in The American Journal of Managed Care, also found an even greater opportunity for cost-savings if medication adherence resources are focused on patients with three or more chronic co-morbidities, such as hypertension, diabetes and high cholesterol. In fact, a preliminary analysis shows that payers could save approximately $38-$63 million per 100,000 members by focusing resources on these specific patient populations.
CVS: 93.61 (+0.25)
After Target (TGT) Earnings, Should Walmart (WMT) Investors Worry?
Ryan McQueeney - Zacks Investment Research - Wed Aug 17, 2:27PM CDT
Target missed revenue expectations and slashed its guidance for the remainder of the year, which could be a sign of things to come for Walmart (WMT), another giant in the value shopping sphere that is set to report this week.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), WMT: 72.06 (-0.94), AAPL: 108.36 (+0.66)
Three Reasons For Target's Weak Q2 Sales
Ryan McQueeney - Zacks Investment Research - Wed Aug 17, 1:18PM CDT
Target pointed to these three areas to explain why its same-store sales declined.
TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), AAPL: 108.36 (+0.66)
CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Colorado
PR Newswire - Wed Aug 17, 8:30AM CDT
CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Colorado. CVS Health has established a standing order with physicians in Colorado that allows CVS Pharmacy to expand access to the medication across the state.
CVS: 93.61 (+0.25)
Can Target Withstand Amazon’s Wrath?
ESTMZ - Tue Aug 16, 3:30PM CDT
Target Corp ( TGT ) Consumer Discretionary - Multiline Retail | Reports August 17, Before Market Opens Key Takeaways The Estimize consensus is looking for earnings per share of $1.14 on $16.25 billion in revenue, 1 cent higher than Wall street...
AMZN: 784.48 (-4.39), SPY: 219.01 (-0.02), TGT: 70.30 (+0.20), CVS: 93.61 (+0.25), WMT: 72.06 (-0.94)
5 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Tue Aug 16, 3:00PM CDT
Target ( TGT ): The discounter is the fifth largest retailer in the world, after Walmart, CVS, Walgreens and Home Depot. While Walmart has traditionally been a direct competitor for Target, it’s Amazon that is now becoming a bigger threat. Over the...
SPLS: 8.79 (+0.22), AMZN: 784.48 (-4.39), HD: 132.79 (-1.31), SPY: 219.01 (-0.02), WBA: 82.88 (+1.24), PLCE: 83.03 (-0.06), AEO: 18.46 (+0.06), TGT: 70.30 (+0.20), WMT: 72.06 (-0.94), CVS: 93.61 (+0.25), LOW: 75.44 (-0.57)
CVS Caremark (CVS) Breaks Through Support at $97.25
Comtex SmarTrend(R) - Tue Aug 16, 8:47AM CDT
Shares of CVS Caremark (NYSE:CVS) opened today below their pivot of $97.46 and have already reached the first level of support at $97.25. Investors may be interested in a cross of the next downside pivot targets of $96.92 and $96.38.
CVS: 93.61 (+0.25)
CVS Health Survey Reveals Two in Five Americans Make Multiple Trips to get Entire Household Vaccinated against the Flu
PR Newswire - Tue Aug 16, 7:30AM CDT
A new survey from CVS Health (NYSE:CVS) released today found that more than one-third (34 percent) of U.S. adults who have ever received the flu shot determine where to get vaccinated based on convenience. Specific convenience factors that would make Americans more likely to have themselves and their families vaccinated against the flu include having the vaccine readily available without an appointment (28 percent) and being able to get the entire family vaccinated at one place/time (20 percent).
CVS: 93.61 (+0.25)
